Polaris Partners

@PolarisVC

Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators. Learn more at polarispartners.com.

Boston, SF & New York polarispartners.com Joined September 2010

794 Following 6.6K Followers 3K Posts

Latest posts 5

Polaris Partners @PolarisVC Nov 7, 2023

Congrats to the @dewpoint_tx team on the strategic partnership with @Evotec. Read more here: globenewswire.com/news-release/2…

www.globenewswire.com Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline PARTNERSHIP TO ACCELERATE DEWPOINT’S LEADING ONCOLOGY PIPELINE PROGRAMS TO INVESTIGATIONAL NEW DRUG APPLICATIONS COLLABORATION LEVERAGES EVOTEC’S FULLY...

Polaris Partners @PolarisVC Nov 3, 2023

Congrats to @BeMeHQ on partnering with major health plans to support teen mental health. Read more here: medcitynews.com/2023/11/teen-m…

medcitynews.com BeMe Health Partners With 2 Health Plans To Support Teen Mental Health - MedCity News BeMe Health, a digital mental health company for teens, is teaming up with Inland Empire Health Plan and Molina Healthcare of California to bring BeMe's platform to 10 local educational agencies. The...

Polaris Partners @PolarisVC Oct 31, 2023

Congrats to the Engine Biosciences team on today's funding round to advance the development of precision oncology medicines. Read more here: finance.yahoo.com/news/engine-bi…

Polaris Partners @PolarisVC Oct 30, 2023

Congrats to the @VolastraTx team on this milestone

Volastra Therapeutics @VolastraTx Oct 30, 2023

We've dosed the first patient in our #clinicaltrial of VLS-1488, our internally discovered #KIF18A inhibiting drug designed to treat patients with advanced cancers characterized by high levels of chromosomal instability: bit.ly/3QkleIb.

View quoted post on X

Polaris Partners @PolarisVC Oct 26, 2023

We are pleased to see Triveni Bio up and running! Formed with important contributions from Polaris Partners repeat entrepreneurs Tillman Gerngross and Leonard Zon at Amagma, now Triveni. Read more here: biopharmadive.com/news/triveni-b…

www.biopharmadive.com Triveni emerges from biotech merger with $92M for immune disease drugs Backed by investors like Atlas and Cormorant, Triveni is developing an antibody drug for eczema and asthma that takes aim at a different kind of target.